Skip to main content
logo
ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.670
+0.080 (5.03%)
Apr 24, 2026, 4:00 PM EDT - Market closed

ALX Oncology Holdings Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
224.72M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Keros Therapeutics244.06M
Heron Therapeutics154.90M
Fennec Pharmaceuticals44.64M
Voyager Therapeutics40.37M
MediWound16.96M
Camp4 Therapeutics3.50M
Milestone Pharmaceuticals1.55M
Revenue Rankings

ALXO News

More News